Bollard Group LLC Zoetis Inc. Transaction History

Bollard Group LLC

$3.76 Billion
Q3 2024

A detailed history of Bollard Group LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Bollard Group LLC holds 3,000 shares of ZTS stock, worth $489,930. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,000

Previous 3,000 -0.0%

Holding current value

$489,930

Previous $520,000 12.69%

% of portfolio

0.02%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$167.14 - $192.77 $8,022 - $9,252	-48 Reduced 1.57%	3,000 $522,000
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $7,242 - $8,380	45 Added 1.5%	3,048 $525,000
Q1 2023 May 12, 2023	BUY	$145.48 - $175.02 $435,712 - $524,184	2,995 Added 37437.5%	3,003 $500,000
Q4 2022 Feb 10, 2023	SELL	$131.14 - $157.47 $462,268 - $555,081	-3,525 Reduced 99.77%	8 $1,000
Q3 2022 Nov 09, 2022	BUY	$148.29 - $182.55 $1,038 - $1,277	7 Added 0.2%	3,533 $524,000
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $102,472 - $131,459	-657 Reduced 15.71%	3,526 $606,000
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $1,269 - $1,638	7 Added 0.17%	4,183 $789,000
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $968 - $1,235	5 Added 0.12%	4,176 $1.02 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $946 - $1,048	5 Added 0.12%	4,171 $810,000
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $935 - $1,127	6 Added 0.14%	4,166 $776,000
Q1 2021 May 11, 2021	BUY	$144.0 - $169.39 $504,000 - $592,865	3,500 Added 530.3%	4,160 $655,000
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $73,867 - $94,069	660 New	660 $90,000

Others Institutions Holding ZTS

# of Institutions

1,958

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Zoetis Inc. Transaction History